U of M drug gets a second chance to make it to market

The drug was initially licensed to a company that recently filed for Chapter 7 bankruptcy. Now Colorado-based Ariel Pharmaceuticals has picked up Tamiasyn and will take over the task of preparing it for human clinical trials.
Author:
Publish date:
Social count:
0

The drug was initially licensed to a company that recently filed for Chapter 7 bankruptcy. Now Colorado-based Ariel Pharmaceuticals has picked up Tamiasyn and will take over the task of preparing it for human clinical trials.

Related

U of M president picks alum for second-in-command

Incoming VP and Provost Karen Hanson brings a background in the humanities at a time when the liberal arts are under attack. University President Eric Kaler says her education will help balance his own as an engineer. Hanson has said that making the case for the humanities "will have to be made again and again."

U of M, Mayo Clinic cultivate close ties to drug companies

In part three in a series investigating drug company's financial relationships with health care practitioners, the Pioneer Press looks into the University of Minnesota and Mayo Clinic, two big organizations that are getting a growing share of industry money. Both organizations use the money for research and training, and both have processes in place to root out possible conflicts of interest.

U of M professor: Drugs aren't solution to kids' attention problems

A psychology professor from the University of Minnesota is making waves with an article in the Sunday New York Times. L. Alan Sroufe says medicating children is a misguided approach to treating attention disorders. "Putting children on drugs does nothing to change the conditions that derail their development in the first place," he writes.

Minnesota seeks to limit psych drugs for kids

Concerned by a sharp rise in the use of powerful psychiatric drugs for adolescents, Minnesota will start requiring doctors in many cases to begin using a state-funded consulting service before prescribing such medications for children. The state Department of Human Services has awarded a two-year contract to Mayo Clinic to run the service.

Next Up